Application of drug combination of vitamin K1 and temozolomide in preparation of medicine for treating cholangiocarcinoma
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 阿耳法猫(杭州)人工智能生物科技有限公司
- Publication Date
- 2021-05-28
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine, and particularly relates to the application of vitamin K1 and temozolomide in combination in preparing a medicine for treating cholangiocarcinoma. Background technique
[0002] Cholangiocarcinoma is a malignant tumor originating from bile duct epithelial cells and is the second most common malignant tumor of the hepatobiliary system after liver cancer. The overall mortality of hepatobiliary malignancies ranks fifth among all malignant tumors. my country is a high-incidence area of cholangiocarcinoma, and the incidence has been increasing in recent years. Cholangiocarcinoma is highly aggressive, only 30% to 40% of patients can be effectively treated by surgical resection at the time of diagnosis, while most patients are diagnosed at an advanced stage, lacking effective treatment methods, and the prognosis is extremely poor.
[0003] Temozolomide is a first-line chemotherapeutic drug against malignant g...